Adcock Ingram at a Glance
ADCOCK INGRAM HOLDINGS LIMITED
Our business model
- Our Capitals Defined
- Our Capital Inputs
- Our Capitals Outcomes
Our strategic focus
Adcock Ingram presented its priorities at the start of the financial year which incorporated the following three focus areas:
- BUILD ON THE FOUNDATION
- GROWTH AND EXPANSION
- TRANSFORMATION
Leadership review from our Chairman and CEO
We are pleased to present the Company’s 2019 Integrated Report to stakeholders. Despite a multitude of challenging factors, our financial results are testament to the fact that the business is progressing at a balanced pace.
- OVER THE COUNTER
- PRESCRIPTION
- HOSPITAL
- CONSUMER
Over the Counter
A closer look at our Operating Model
OUR BUSINESS ACTIVITIES
The OTC division supplies medication for patients in South Africa’s private and public sectors as well as certain export markets, predominantly in the self–medication category and to a lesser extent in the FMCG channel.
Prescription
A closer look at our Operating Model
OUR BUSINESS ACTIVITIES
The division focuses on building and offering a broad range of medicines in targeted therapeutic areas for patients consulting healthcare professionals, generally where prescriptions are required.
Hospital
A closer look at our Operating Model
OUR BUSINESS ACTIVITIES
Adcock Ingram Critical Care (AICC) is a leading manufacturer and supplier of hospital and critical care products in Southern Africa. Products are offered through multiple portfolios and across wide-ranging customer channels. The business is a fully integrated operation which spans through regulatory, R & D, manufacturing, marketing, sales and distribution.
Consumer
A closer look at our Operating Model
OUR BUSINESS ACTIVITIES
This division is focused on the marketing, selling and distribution of medicinal and personal care brands.
Our ranges include brands in the analgesic, energy, colds & flu, feminine hygiene, personal care, gut health, nutrition and vitamins & supplements categories.